Lu S. Wang
270 Dong An Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Potentiating BSEP-mediated bile acid efflux reverses first-line tyrosine kinase inhibitor resistance in hepatocellular carcinoma.
Journal: Cancer letters
Published: November 27, 2025
Self-Amplifying Redox Dyshomeostasis: An All-Active Fenton/Diselenium-Based Nanocomposite for Multimechanistic Cancer Therapy.
Journal: Advanced healthcare materials
Published: October 30, 2025
Combining AI to reveal CCDC3-mediated pathways of colorectal cancer liver metastasis.
Journal: NPJ digital medicine
Published: October 10, 2025
Orosomucoid 2 promotes colorectal cancer liver metastasis by suppressing natural killer cell-mediated antitumor immunity by remodeling the serine and one-carbon metabolism pathway.
Journal: Molecular cancer
Published: September 06, 2025
A technological convergence in hepatobiliary oncology: Evolving roles of smart surgical systems.
Journal: Bioscience trends
Published: August 03, 2025
TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysis.
Journal: European radiology experimental
Published: July 31, 2025
Advances in research on receptor heterogeneity in breast cancer liver metastasis.
Journal: Bioscience trends
Published: April 16, 2025
SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 30, 2025
SENP3 induced HADHA deSUMOylation enhances intrahepatic cholangiocarcinoma chemotherapy sensitivity via fatty acid oxidation.
Journal: Cancer letters
Published: February 10, 2025
Last Updated: 09/26/2026